An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease?

Photo by Fusion Medical Animation on Unsplash

Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. VIRI, was a guest speaker at Benzinga’s All Access on Jan. 28, 2022. 

Greg discussed Virios Therapeutics’ mission and the clinical-stage company’s ongoing progress in developing innovative antiviral therapies to treat diseases - like fibromyalgia (FM) and related health concerns. 

Watch the full interview here.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechGeneralPartner ContentVirios Therapeutics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!